Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junlong Wu

Showing results (121-130 of 124) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 124 results.
Signal Transduction and Targeted Therapy|April 12, 2026
Deutenzalutamide, a novel androgen receptor inhibitor, after progression on docetaxel and abiraterone in metastatic castration-resistant prostate cancer: results from the randomized phase III HC-1119-04 trialJunlong Wu, Xinghai Li, Chengyuan Gu, et al.
Cell Reports. Medicine|December 10, 2024
Development and validation of the utLIFE-PC algorithm for noninvasive detection of prostate cancer in urine: A prospective, observational studySujun Han, Mingshuai Wang, Yong Wang, et al.
Journal of Clinical Neurology (Seoul, Korea)|January 10, 2026
Efficacy, Safety, and Tolerability of Subcutaneous Efgartigimod PH20 in Chinese Patients With Chronic Inflammatory Demyelinating Polyneuropathy: A Prespecified Subpopulation Analysis of the Multicentre, Randomised-Withdrawal, Double-Blind, Placebo-Controlled, Phase II ADHERE TrialJie Lin, Man Ding, Qinzhou Wang, et al.
Nature Communications|March 26, 2026
Atlas of predicted protein complex structures across kingdomsXianzhi Qi, Cheng Ye, Jianqiang Liang, et al.
Pageof 13

Showing results (121-130 of 124) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 124 results.
Signal Transduction and Targeted Therapy|April 12, 2026
Deutenzalutamide, a novel androgen receptor inhibitor, after progression on docetaxel and abiraterone in metastatic castration-resistant prostate cancer: results from the randomized phase III HC-1119-04 trialJunlong Wu, Xinghai Li, Chengyuan Gu, et al.
Cell Reports. Medicine|December 10, 2024
Development and validation of the utLIFE-PC algorithm for noninvasive detection of prostate cancer in urine: A prospective, observational studySujun Han, Mingshuai Wang, Yong Wang, et al.
Journal of Clinical Neurology (Seoul, Korea)|January 10, 2026
Efficacy, Safety, and Tolerability of Subcutaneous Efgartigimod PH20 in Chinese Patients With Chronic Inflammatory Demyelinating Polyneuropathy: A Prespecified Subpopulation Analysis of the Multicentre, Randomised-Withdrawal, Double-Blind, Placebo-Controlled, Phase II ADHERE TrialJie Lin, Man Ding, Qinzhou Wang, et al.
Nature Communications|March 26, 2026
Atlas of predicted protein complex structures across kingdomsXianzhi Qi, Cheng Ye, Jianqiang Liang, et al.
Pageof 13